Clinical Trial

Apremilast and Adalimumab in Psoriatic Arthritis Patients

Name: Apremilast and Adalimumab in Psoriatic Arthritis Patients — clinical trial record (NCT07398651)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The aim of this work is to compare the efficacy of Apremilast combined with Methotrexate versus Adalimumab combined with Methotrexate

Trial Details

NCT Number	NCT07398651
Lead Sponsor	Tanta University
Conditions	Psoriatic Arthritis, Ultrasound Assessment, TNF
Enrollment	60 participants
Start Date	2026-12-30
Primary Completion	2026-12-30 (estimated)
Study Completion	2026-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-10